Clinical Trials Sponsored by Heart Center BH Tuzla
Total 1 results
-
Heart Center BH TuzlaUnknownPatients With Coronary Artery Disease Scheduled for by Pass SurgeryBosnia and Herzegovina
Sponsors and Collaborators
- Celtaxsys Aus Pty Limited
- CRMBM-CEMEREM
- The Fifth Affiliated Hospital of Zunyi Medical College
- Rui-hua Xu, MD, PhD
- Donders Institute for Brain, Cognition and Behavior
- Cardresearch
- AMTC & Associates
- San MediTech(Huzhou)Co.,Ltd.
- Ilustre Colegio Profesional de Fisioterapeutas de la Comunidad de Madrid
- University Medical Center Goettingen
- Diego Hernan Giunta, MD
- Alberta Children's Hospital, Calgary, Canada
- Elim Pediatric Pharmaceuticals Inc.
- Caritas Freetown
- Fondren Orthopedic Group L.L.P.
- ProteoSys AG
- Victor Montori
- Norsk Proteinintolerance, Norway
- University Centre for Chronic Diseases Dekkerswald, Groesbeek, NL
- Societa Italiana di Endoscopia Digestiva
- View Full List
Medical Conditions
- Analgesics, Antipyretics, and Antirheumatics Causing Adverse Effects in Therapeutic Use
- Normal Diameter of Optic Nerve
- Malignant Ascites Due to Epithelial Carcinoma
- Stereotactic Radioablation for Ventricular Tachycardia
- Lymphedema of Arm
- Plasmodium Falciparum Malaria (Drug Resistant)
- Tube Disorders Eustachian
- Non-compressible Torso Hemorrhage
- Fibromyalgia Syndrome, Primary
- Tularaemia
- Orbital Tumor
- Non-dystrophic Myotonias
- Prostate Cancer Recurrent
- Atrial Fibrillation, Postoperative
- Gynecologic Cancer
- Spermatogenesis Arrest
- Disturbance of Activity and Attention
- Postcomatose Unawareness State
- Fever, Sweats, and Hot Flashes
- Auditory Hallucination, Verbal
- View Full List
Drug Interventions
- Enzalutamide, Abiraterone
- Oxycodone, fentanyl
- Flibanserin 100 mg dose every evening
- Methotrexate
- Lamivudine
- CTx-1301-Dexmethylphenidate 18.75mg (randomized fixed dose)
- Cytarabine ARA-C
- Bortezomib/dexamethasone
- Polyethylene glycol 3350
- PF-00868554
- Cetrorelix 78 mg + 78 mg
- SERETIDE Diskus
- HB-202 / HB-201 alternating intravenous administration + standard of care regimen including pembrolizumab.
- Mupirocin Calcium
- Atezolizumab
- Topotecan
- Insulin
- Indoximod
- Ruxolitinib
- Epimedium Prenylflavonoids Extract
- View Full List
CROs by country
- Contract Research Organizations in Angola
- Contract Research Organizations in Australia
- Contract Research Organizations in Bahrain
- Contract Research Organizations in Benin
- Contract Research Organizations in Djibouti
- Contract Research Organizations in Hungary
- Contract Research Organizations in Moldova
- Contract Research Organizations in Myanmar
- Contract Research Organizations in Romania
- Contract Research Organizations in Suriname
- Contract Research Organizations in Tunisia
- Contract Research Organizations in United Arab Emirates
- Contract Research Organizations in Uzbekistan
- CRO list by country